A Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP of the European Pharmacopoeia monograph is often referred to as a Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate Certificate of Suitability (COS). The purpose of a Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate to their clients by showing that a Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP has been issued for it. The manufacturer submits a Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP holder for the record. Additionally, the data presented in the Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate DMF.
A Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fungisdin, Albistat, Andergin, Daktacort, Miconazole nitrate suppliers with CEP (COS) on PharmaCompass.